Act Up-Paris affichette "Glaxo Trizivir / Guilty " (Coupable) France 2002/7/11 2002.110.8 Photo Mucem
Act Up-Paris affichette "Glaxo Trizivir / Guilty " (Coupable) France 2002/7/11 2002.110.8 Photo Mucem

affichette, "Glaxo Trizivir / Guilty " (Coupable)

Numéro d'inventaire : 2002.110.8

Description

  • Création

    De : Lieux : 
    • France
    • Espagne
    • Barcelone
    Date : 11 juillet 2002
  • Description détaillée

    Affiche en papier blanc de format A3, tenue verticalement présentant, imprimés en négatif, un très long texte. Celui-ci présente la liste des effets secondaires du traitement, en anglais. Au centre apparaît un comprimé ovale de trizivir, en blanc.
    Sont écrits en gros certains termes dans chaque répétition de liste, ce qui les met en relief : fatigue, abdominal pain, Insomnia , hypersensitivity, nausea. Le logo de l'association est imprimé dans le coin inférieur droit.
  • Inscriptions

    Titre

    Glaxo / GUILTY, en haut

    Texte

    Act Up-Paris demands post marketing approval studies : / // - prospective research of side effects on long term / - studies in "real life" conditions / - specific studies on women, children, drug users / and coinfected peoples., en bas
    Headaches, fever, chills, muscle soreness, fatigue, anemia, nausea, and fingernail discolora- / tion. AZT has been associated with bone marrow suppression : anemia and/or neutropenia, particu- / larly in people with advanced HIV. Potential for severe anemia requiring blood transfusion or hospitali- / zation when used with hydroxyurea. Prolonged use of AZT has been associated with symptomatic / myopathy (muscle damage). Rare but potentially fatal toxicity with all NRTIs : pancreatitis (signs inclu- / de nausea, vomiting and abdominal pain that often spreads to the / chest and back); lactic acidosis (seen mostly in women, especially obese women; greater risk for / people with underlying liver disease; signs include deep muscle fatigue especially in legs, and diffi- / cult breathing)and enlarged fatty liver (called hepatomegaly with steatosis; check for tenderness / below ribs on right side ). Insomnia, malaise (overall ill feeling, as with the / blashs, fatigue or a flu), nasal symptoms, cough and peripheral neuropathy. in children, may cause pan- / creatitis, a potentially fatal condition. Children should be monitored carefully for this condition. / Symptoms include nausea, vomiting, clammy skin, and stomach pain that often extends to the back, / among with increased amylase in the blood. Hypersensitivity / (allergic reaction) can be fatal. People / experiencing hypersensitivity must stop / taking Ziagen and cannot take it again (cal- / led rechallenging), because of life- / threatening, and in at least three cases, fatal reaction. Hypersensitivity usually occurs within six weeks / of starting therapy, gets progressively worse and resolves quickly after permanent discontinuation. / Approximately 5 % of people taking Ziagen experienced hypersensitivity during clinical trials. The pri- / mary symptom is low-grade fever with multi-organ symptoms : muscle ache, nausea, vomiting or other / gastrointestinal upset (including abdominal pain), malaise (run-down feeling, as with the blashs, fatigue / or a flu), respiratory symptoms (cough, difficult breathing and sore throat) and possibly mils rash. / Hypersensitivity might be confused with flu during flu / season. The manufacturer recommends that people with symptoms of acute respiratory disease / consider hypersensitivity even if other diagnosis as pneumonia, bronchitis or flu is possible. If / hypersensitivity is suspected, stop therapy and contact your doctor immediately. There should be no / problem if you miss your doses for a few days and did not have an allergic reaction. Black / box warning strengthened last year when hypersensitivity was not recognized and people went back / on Ziagen, becoming seriously ill. (répétée deux fois :)
  • Décor

    • femme, trizivir, enfance, hépatite, zap, usage de drogue, Glaxo, laboratoire pharmaceutique, ziagen, essai clinique
  • Matériaux et techniques

    • papier : impression
  • Dimensions et poids

    • Largeur : 29 cm
    • Longueur : 41.5 cm
    • Poids : 11.2 grammes
  • Provenance et historique

    Découverte - collecte

    campagne Sida

    Acquisition

    Date : 23/01/2002
    Acteur : Act Up-Paris (Donateur)
  • Mots-clés

Sur le même thème

Une question ? Une suggestion ? Une demande ?